Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 8 Pain 6 Breast Neoplasms 6 Prostatic Neoplasms 5 Pain, Postoperative 4 Neuralgia 4 Lung Neoplasms 4 Keratosis, Actinic 4 Agnosia 4 Neoplasms 3 Myofibroma 2 Leiomyoma 2 Inflammatory Bowel Diseases 2 Diverticulitis 2 Colonic Neoplasms 2 Cancer Pain 2 Uterine Neoplasms 1 Tuberculosis 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Scleroderma, Localized 1 Sarcoidosis 1 Prostate Biopsy 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Patient Satisfaction 1 Paget Disease, Extramammary 1 Ovarian Cysts 1

Interventions

tremelimumab 1 durvalumab 1 Sodium Chloride 1 Radiotherapy 1 Lidocaine 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cystectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Invasive Bladder Cancer × Lidocaine × Clear all

NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡